Guangyu Yao

1.8k total citations
45 papers, 1.4k citations indexed

About

Guangyu Yao is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Guangyu Yao has authored 45 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Guangyu Yao's work include Nanoplatforms for cancer theranostics (6 papers), Breast Cancer Treatment Studies (6 papers) and Peptidase Inhibition and Analysis (4 papers). Guangyu Yao is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), Breast Cancer Treatment Studies (6 papers) and Peptidase Inhibition and Analysis (4 papers). Guangyu Yao collaborates with scholars based in China, United States and Switzerland. Guangyu Yao's co-authors include Eran R. Andrechek, Michael L. Gatza, Noriomi Matsumura, Jae‐Weon Kim, Tsukasa Baba, Jean Chang, Seiichi Mori, Joseph R. Nevins, Susan K. Murphy and Changsheng Ye and has published in prestigious journals such as Advanced Materials, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Guangyu Yao

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangyu Yao China 20 638 359 346 294 226 45 1.4k
Sang‐Yeob Kim South Korea 24 797 1.2× 440 1.2× 266 0.8× 262 0.9× 271 1.2× 81 1.6k
Suxia Han China 24 1.0k 1.6× 445 1.2× 228 0.7× 518 1.8× 159 0.7× 75 1.8k
Mariana Varna France 21 589 0.9× 566 1.6× 240 0.7× 361 1.2× 116 0.5× 40 1.5k
Shanzhou Duan China 19 529 0.8× 261 0.7× 302 0.9× 186 0.6× 141 0.6× 40 1.2k
Aaron Goldman United States 23 727 1.1× 494 1.4× 321 0.9× 267 0.9× 149 0.7× 49 1.5k
Yun Zhu China 23 522 0.8× 253 0.7× 409 1.2× 244 0.8× 113 0.5× 63 1.3k
Huanrong Lan China 22 474 0.7× 448 1.2× 174 0.5× 254 0.9× 187 0.8× 62 1.1k
Xiaofei Wen China 16 468 0.7× 247 0.7× 233 0.7× 259 0.9× 149 0.7× 54 1.1k
Xuyong Wei China 26 1.1k 1.7× 408 1.1× 288 0.8× 463 1.6× 211 0.9× 127 2.3k
Rita Mendes Portugal 11 590 0.9× 415 1.2× 414 1.2× 301 1.0× 268 1.2× 16 1.4k

Countries citing papers authored by Guangyu Yao

Since Specialization
Citations

This map shows the geographic impact of Guangyu Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangyu Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangyu Yao more than expected).

Fields of papers citing papers by Guangyu Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangyu Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangyu Yao. The network helps show where Guangyu Yao may publish in the future.

Co-authorship network of co-authors of Guangyu Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Guangyu Yao. A scholar is included among the top collaborators of Guangyu Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangyu Yao. Guangyu Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Deng, Shaohui, et al.. (2024). Overcoming the Tumor Collagen Barriers: A Multistage Drug Delivery Strategy for DDR1‐Mediated Resistant Colorectal Cancer Therapy. Advanced Science. 11(33). e2402107–e2402107. 8 indexed citations
4.
Zhang, Yunjiao, Xiaowan Huang, Cong Cao, et al.. (2021). Glutathionylation-dependent proteasomal degradation of wide-spectrum mutant p53 proteins by engineered zeolitic imidazolate framework-8. Biomaterials. 271. 120720–120720. 24 indexed citations
5.
Wang, Zhiyu, Jing Sun, Yi Sun, et al.. (2021). Machine Learning Algorithm Guiding Local Treatment Decisions to Reduce Pain for Lung Cancer Patients with Bone Metastases, a Prospective Cohort Study. Pain and Therapy. 10(1). 619–633. 15 indexed citations
6.
Yao, Guangyu, Yiyi Zhou, Yifeng Gu, et al.. (2020). Value of combining PET/CT and clinicopathological features in predicting EGFR mutation in Lung Adenocarcinoma with Bone Metastasis. Journal of Cancer. 11(18). 5511–5517. 11 indexed citations
7.
He, Ding, Yang Song, Xiaowan Huang, et al.. (2020). mTORC1-dependent TFEB nucleus translocation and pro-survival autophagy induced by zeolitic imidazolate framework-8. Biomaterials Science. 8(15). 4358–4369. 17 indexed citations
8.
Bao, Youmei, Shenqi Zhang, Zeming Chen, et al.. (2020). Synergistic Chemotherapy for Breast Cancer and Breast Cancer Brain Metastases via Paclitaxel-Loaded Oleanolic Acid Nanoparticles. Molecular Pharmaceutics. 17(4). 1343–1351. 55 indexed citations
9.
Chen, Lujia, et al.. (2019). Short-duration versus 1-year adjuvant trastuzumab in early HER2 positive breast cancer: A meta-analysis of randomized controlled trials. Cancer Treatment Reviews. 75. 12–19. 32 indexed citations
10.
11.
Yao, Guangyu, et al.. (2017). Pretreatment Hematocrit is Negatively Associated with Response to Neoadjuvant Chemotherapy in Breast Cancer. Biomarkers in Medicine. 11(9). 713–720. 3 indexed citations
12.
He, Ping, et al.. (2016). Diagnosis of lung adenocarcinoma in situ and minimally invasive adenocarcinoma from intraoperative frozen sections: an analysis of 136 cases. Journal of Clinical Pathology. 69(12). 1076–1080. 30 indexed citations
13.
Yao, Guangyu, Lujia Chen, Xiaolei Hu, Wenji Li, & Changsheng Ye. (2016). [Expression pattern of membrane type-1 matrix metalloproteinase in primary breast carcinomas].. PubMed. 36(1). 94–7.
15.
Yao, Guangyu, et al.. (2014). Risk-Association of Five SNPs in TOX3/LOC643714 with Breast Cancer in Southern China. International Journal of Molecular Sciences. 15(2). 2130–2141. 22 indexed citations
16.
Huang, Dingzhi, Haiyan Wang, Rui Liu, et al.. (2013). miRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer. Journal of Cellular Biochemistry. 115(3). 549–556. 62 indexed citations
17.
Yao, Guangyu, et al.. (2013). MT1-MMP in breast cancer: induction of VEGF-C correlates with metastasis and poor prognosis. Cancer Cell International. 13(1). 98–98. 21 indexed citations
18.
Li, Haiyan, Jun Lin, Xiaokai Wang, et al.. (2012). Targeting of mTORC2 prevents cell migration and promotes apoptosis in breast cancer. Breast Cancer Research and Treatment. 134(3). 1057–1066. 67 indexed citations
19.
Zhang, Yue, Song Xu, Jun Lin, et al.. (2012). mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo. Breast Cancer Research and Treatment. 136(2). 379–388. 19 indexed citations
20.
Mori, Seiichi, Jean Chang, Eran R. Andrechek, et al.. (2009). Anchorage-independent cell growth signature identifies tumors with metastatic potential. Oncogene. 28(31). 2796–2805. 265 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026